Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did 😎Read how

EnerSys To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Wednesday

Published 20/12/2023, 12:50
© Reuters.  EnerSys To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Wednesday

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

  • Raymond James boosted Teleflex Incorporated (NYSE: TFX) price target from $227 to $271. Raymond James analyst Jayson Bedford maintained an Outperform rating. Teleflex shares rose 0.2% to close at $253.83 on Tuesday. See how other analysts view this stock.
  • Citigroup increased the price target for MacroGenics, Inc. (NASDAQ: MGNX) from $7 to $13. Citigroup analyst Yigal Nochomovitz upgraded the stock from Neutral to Buy. MacroGenics shares gained 6.3% to close at $9.23 on Tuesday. See how other analysts view this stock.
  • Stifel raised the price target for Lowe's Companies, Inc. (NYSE: LOW) from $235 to $240. Stifel analyst W. Andrew Carter downgraded the stock from Buy to Hold. Lowe's shares gained 0.6% to close at $225.42 on Tuesday. See how other analysts view this stock.
  • Wells Fargo increased the price target for Paramount Global (NASDAQ: PARA) from $15 to $18. Wells Fargo analyst Steven Cahall upgraded the stock from Underweight to Equal-Weight. Paramount Global shares rose 2% to close at $15.82 on Tuesday. See how other analysts view this stock.
  • Piper Sandler boosted the price target for Newmark Group, Inc. (NASDAQ: NMRK) from $7 to $13. Piper Sandler analyst Alexander Goldfarb upgraded the stock from Neutral to Overweight. Newmark shares gained 1% to close at $10.07 on Tuesday. See how other analysts view this stock.
  • Citigroup boosted Mirati Therapeutics, Inc. (NASDAQ: MRTX) price target from $48 to $59. Citigroup analyst Yigal Nochomovitz downgraded the stock from Buy to Neutral. Mirati Therapeutics shares gained 1.7% to close at $58.78 on Tuesday. See how other analysts view this stock.
  • HC Wainwright & Co. raised Marathon Digital Holdings, Inc. (NASDAQ: MARA) price target from $20 to $24. HC Wainwright & Co. analyst Kevin Dede maintained a Buy rating. Marathon Digital shares gained 10.5% to close at $21.97 on Tuesday. See how other analysts view this stock.
  • UBS cut Coupang, Inc. (NYSE: CPNG) price target from $26 to $18.5. UBS analyst Jennifer Han downgraded the stock from Buy to Neutral. Coupang shares rose 1.9% to close at $16.46 on Tuesday. See how other analysts view this stock.
  • Barclays slashed FedEx Corporation (NYSE: FDX) price target from $330 to $310. Barclays analyst Brandon Oglenski maintained an Overweight rating. FedEx shares fell 0.7% to close at $280.00 on Tuesday. See how other analysts view this stock.
  • Oppenheimer boosted EnerSys (NYSE: ENS) price target from $110 to $116. Oppenheimer analyst Noah Kaye maintained an Outperform rating. EnerSys shares gained 0.7% to close at $96.75 on Tuesday. See how other analysts view this stock.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Check This Out: Insiders Buying Pfizer And 3 Other Stocks

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.